Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II gemcitabine + pemetrexed in pretreated metastatic colorectal cancer
2010-019841-25Phase 2Terminated
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and pemetrexed in colorectal cancer (CRC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Primary endpoint: Objective response rate. Started Aug 2012; status: terminated.
02
Drugs
gemcitabinepemetrexed
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-019841-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019841-25.